Wellorithm vs TMates
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
PickCompounded GLP-1 (semaglutide and tirzepatide, injection or oral) AND real brand-name Wegovy, Ozempic, Mounjaro and Zepbound on one menu. $147 for the first month of compounded semaglutide, then $247/mo, with board-certified obesity specialists and 24/7 support.
from $247/mo regular rate for a one-month supply ($147 first month)
Verified 2026-10-06
Visit →Affiliate link
PickPublishes a complete plan grid with the billed total and the per-month rate for each length, at the same price for every dose. And lists side effects on the product page itself.
from $158/mo on a 12-month plan ($1,900)
Verified 2026-09-17
Visit →Affiliate link
| Wellorithm | TMates | |
|---|---|---|
| Price | from $247/mo regular rate for a one-month supply ($147 first month)Their page, read 2026-10-06 | from $158/mo on a 12-month plan ($1,900)Their page, read 2026-09-17 |
| Price shape | reliable-all-in | one-ongoing-rate |
| What the price doesn’t say | Nothing recorded beyond the figure itself. | $158/mo needs the twelve-month plan at $1,900. Shorter terms: $1,050 for six ($175/mo), $650 for three ($217/mo), $249 for one. Same price at every dose. The $99/mo published for brand-name Zepbound and Wegovy is not used as a starting price. The page never says whether it is cash or insurance-dependent, and its own FAQ says cost depends on your insurance. |
| What it covers | Not published. The page does not say what the figure covers.Their page, read 2026-10-06 | Not published. The page does not say what the figure covers.Their page, read 2026-09-17 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-10-06 | Not recorded. We have not found a statement either way.Their page, read 2026-09-17 |
| Commitment | The page does not state whether a term is required. What happens after the first period: Publishes both figures on its semaglutide card: "first month $147", then "Second month and on. $247" (read 6 October 2026). $247 is the recurring rate shown here; $147 is the first month only..Their page, read 2026-10-06 | The page does not state whether a term is required.Their page, read 2026-09-17 |
| Routes | compounded semaglutide, compounded tirzepatide, oral, brand-name Wegovy/Ozempic/Mounjaro/Zepbound | compounded semaglutide, oral compounded semaglutide tablet, compounded tirzepatide, brand-name Zepbound, brand-name Wegovy, oral phentermine |
| Score | 7.7 | 7.0 |
What one does that the other doesn’t
Wellorithm
Nothing TMates does not also offer, on the routes we record.
TMates
Nothing Wellorithm does not also offer, on the routes we record.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Wellorithm
- Scores clearly higher on clinical (8.0 vs 6.5).Basis: our published scoring rubric
- Scores clearly higher on transparency (8.0 vs 6.5).Basis: our published scoring rubric
- Scores clearly higher on treatment (9.5 vs 8.0).Basis: our published scoring rubric
TMates
- Lower published entry figure of the two.Basis: published entry price, each in its own billing unit
- Scores clearly higher on pricing (7.5 vs 5.5).Basis: our published scoring rubric
Full write-ups: Wellorithm · TMates